After 40, when energy, drive, mental clarity, and circulation don't feel the same as they did at 25, most people assume the body is breaking down.
It's not.
Built on Nobel Prize-winning research in cellular energy and signaling, Juvenon was founded on one idea: the body isn't broken.
What most people don't realize is that the systems responsible for energy, circulation, mental sharpness, and drive didn't break down after 40. They're still there. The body just stopped telling them to fire up.
Until now, everything else on the market has been about adding more. More stimulants. More hormones. More chemicals. More ingredients. More confusion. All designed to "fix" something people thought they lost.
We don't see it that way.
Juvenon was founded at UC Berkeley by Dr. Bruce Ames, one of the most cited biochemists in history and a recipient of the National Medal of Science. His decades of research into aging, DNA damage, and cellular nutrition led to a breakthrough: the body is still capable at any age. Its key systems don't fail. They go quiet over time, and they can be reactivated with the right nutrients at the right dosages.
More recently, our commitment has been strengthened by Dr. Luke Bucci, Chief Science Officer, a highly respected biomedical scientist & clinical nutritionist. Dr. Bucci ensures Juvenon's formulas are developed to a scientific standard we call Beyond Substantiation.
That's why our promise is a simple one: Uncomplicated Longevity.
We’ve developed clinical-grade supplements with targeted ingredients and precise formulations for adults over 40 to reignite the body's key systems, from energy and circulation to mental sharpness, sexual health, and drive.
Our formulas are 3 to 10 times more effective than anything else on the market, because they help the body remember what it already knows how to do.
You still got it. We help turn it back on with simple systems that work.
And once reactivation happens, you’ll discover just how capable you really are, no matter your age.
Every product is made in the USA, third-party tested for purity, and backed by our 60-Day Unconditional Guarantee.
See why over 500,000 happy customers trust Juvenon.
Yours in health,
Nathan Hamilton
CEO, Juvenon LLC
U.C. Berkeley scientists founded Juvenon to make their healthy aging breakthrough available to the public. Now, Juvenon has expanded to multiple products. But Juvenon’s mission remains the same; to empower millions of individuals worldwide to add 5 years of health to their lives. We want to maximize your quality of life no matter what age you are, so you live better longer, and age gracefully.
Juvenon strives toward this mission in several ways. First and foremost, we promote a healthy lifestyle and diet. Our website, www.juvenon.com is jam-packed full of information to assist you in your healthy lifestyle, including recipes, tips and analysis on the latest advances in healthy aging.
Secondly, we sell products that are based on science and that work. Our products use the scientific dose based on research. Customers can feel them working, and they make a noticeable difference in our customers’ lives.
Thirdly, Juvenon proudly supports top quality scientific research in the area of “Healthy Aging”. To this end Juvenon provides funding to the Healthy Aging Program at the Linus Pauling Institute, and has provided substantial funding to the Children’s Hospital Oakland Research Institute.
Ultimately, it’s through the continued support from loyal customers — like you — that allows us to give back. Together we are saving lives and improving quality of life on a global scale, and for that, we honor you and can’t thank you enough!
Dr. Bruce N. Ames, Ph.D. is a renowned scientist with a distinguished academic background, and a Juvenon co-founder. He is a Professor of Biochemistry and Molecular Biology at the University of California, Berkeley. Dr. Ames is also Senior Scientist, Children’s Hospital of Oakland Research Institute. He is a member of the National Academy of Sciences and he was on their Commission on Life Sciences. He was a member of the board of directors of the National Cancer Institute, the National Cancer Advisory Board, from 1976 to 1982. Dr. Ames was the recipient of a leading award for cancer research, the General Motors Cancer Research Foundation Prize (1983), a leading award in environmental achievement, the Tyler Prize (1985), the Gold Medal Award of the American Institute of Chemists (1991), the Glenn Foundation Award of the Gerontological Society of America (1992), and the Lovelace Institutes Award for Excellence in Environmental Health Research (1995), the Achievement in Excellence Award of the Center for Excellence in Education (1996), the Honda Prize of the Honda Foundation, Japan (1996), the Japan Prize, (1997), and the Kehoe Award, American College of Occupational and Environmental Med. (1997), the Medal of the City of Paris (1998), the Joseph Priestley Award (1998), and the U.S. National Medal of Science (1998). His over 540+ publications have resulted in his being among the few hundred most-cited scientists in all fields: 23rd most cited (1973-1984).
Professor Ames has been the international leader in the field of mutagenesis and genetic toxicology for over 40 years. His work has had a major impact on, and changed the direction of, basic and applied research on mutation, cancer, and aging. The development of the Ames mutagenicity test as a practical tool for the detection of potential carcinogens has led to its use in over 3000 laboratories and in all of the major drug and chemical companies, where it has had a major influence in weeding out mutagenic chemicals while it is cheap to do so and before they are introduced into commerce. The current research of Dr. Ames’ on cells focuses on the oxidative damage to DNA and its relationship to mutagenesis, carcinogenesis and the degenerative diseases of aging. His main interest is in the prevention of cancer and other degenerative diseases of aging.

Dr. Tory Hagen, Ph.D. is a co-inventor with Dr. Ames on the patent that Juvenon licensed from the University of California, Berkeley, and co-author with Dr. Ames of Mitochondrial Decay in Aging and its Consequences to the Cell. Dr. Hagen is a Professor, Department of Biochemistry and Biophysics and Principal Investigator and Jamieson Endowed Chair in Healthspan Research at the Linus Pauling Institute at Oregon State University, Corvallis, OR. Previously Dr. Hagen was a Postdoctoral Fellow and Assistant Specialist Research Scientist in the Department of Molecular and Cell Biology at the University of California, Berkeley. He earned his Ph.D. in biochemistry at Emory University.

Nathan D. Hamilton is Juvenon’s Chief Executive Officer and a founder of the business. Mr. Hamilton has been an executive with a number of consumer, biotechnology, medical diagnostic and medical device companies. Mr. Hamilton received his B.A. in Physics from the University of California, Berkeley and his Masters of Business Administration from Harvard University Graduate School of Business.